Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study

Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Vera G. Kalugina, Elena A. Vishneva, Leyla S. Namazova-Baranova
स्वरूप: लेख
भाषा:रूसी
प्रकाशित: Union of pediatricians of Russia 2020-08-01
श्रृंखला:Педиатрическая фармакология
विषय:
ऑनलाइन पहुंच:https://www.pedpharma.ru/jour/article/view/1858
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन